The healthcare giant has had trouble winning over investors in the past year despite an incredibly low valuation.
If you are wondering whether Pfizer's current share price reflects its underlying value, you are not alone. This article will ...
Pfizer has outperformed the S&P 500 since my previous call, driven by improving fundamentals and renewed share price momentum ...
Zacks Investment Research on MSN
Pfizer Inc. (PFE) is attracting investor attention: Here is what you should know
Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past ...
Every investor in Pfizer Inc. (NYSE:PFE) should be aware of the most powerful shareholder groups. With 66% stake, ...
All three of these stocks sport dividend yields above 6%.
Despite additional cost savings in 2026, Pfizer also forecasts that its adjusted earnings per share (EPS) will likely decline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results